Monday, November 24, 2014 8:37:03 PM
"I promise you this will be my last response to your posts..."
Thank heavens for that! Im sure I wasnt the only one getting tired of you dodging the questions and resorting to ad hominem attacks in a desperate attempt to discredit the poster.
I'll have the last word on this.
The fact remains - inflammation is NOT the cause of heart disease despite what you may believe. It is a major contributing factor but there has to be an underlying reason for persistent chronic inflammation in the first place. It does not just spontaneously manifest on a whim and then mysteriously hang around for years and decades for no reason. There is a reason adults and the elderly primarily suffer from CV disease and chronic inflammation rather than babies and teens.
This article is well worth a read:
http://www.huffingtonpost.com/dr-mark-hyman/is-your-body-burning-up-w_b_269717.html
"Everyone is treating the downstream effects of inflammation, but addressing the causes of inflammation that are upstream could help people who have multiple problems that are really linked together by this common root cause."
What was I saying about hacking at the branches?
Here's an excellent article about "What causes inflammation?" :
http://thedoctorweighsin.com/what-causes-inflammation-comprehensive-look-at-the-causes-and-effects-of-inflammation/
"Inflammation is the body’s natural response to injury. Although the symptoms of acute inflammation are unpleasant, they are necessary for the healing processes the body goes through. The characteristic symptoms are pain, redness, heat, swelling, and loss of mobility."
"When inflammation doesn’t go away, it is known as chronic or systemic inflammation, and it is no longer a pro-healing response, but rather a symptom that something has gone wrong."
"Many factors can cause a dysregulated immune response and lead to chronic inflammation. Some are genetic, and cannot be changed. More often, however, they are lifestyle factors, and completely changeable. Today, the biggest factor is weight–excess fat tissue leads to chronic inflammation.
Following weight, food is the next biggest factor, not just what we eat but what we should be eating. Smoking is a significant source of inflammation as well. After these factors, UV radiation, stress, and environmental toxins such as pesticides can be sources of inflammation as well."
"For the majority of individuals with chronic inflammation, it serves as a precursor for chronic disease, most of which are far more preventable than curable at this point. For many chronic diseases, the pathogenesis, or onset of disease, takes a long time–often at least twenty years"
"Studies have shown that chronic inflammation directly leads to a damaged endothelium, the lining of our blood vessels, and has an important but not yet fully understood role in the formation of the plaques which clog them.
While other factors, such as high blood cholesterol, are critical to the development of heart diseases as well, it now seems that inflammation is the match that starts the blaze–without an elevated level of CRP to help the formation of blood vessel clogging plaques, they would never be formed, even if all other factors were present."
EPA and AA also get a mention in the article.
So what does all this mean for Amarin and Vascepa. Well, the drug works, and it works by reducing inflammation and plaque build up. It is not going to cure anything because it doesnt remove the underlying causes of inflammation. It will, however, buy the patient more time while the geniuses of the medical community try to connect the dots. Dont hold your breath waiting for them to figure it out. Do your own research. You do not need to be a genius to figure this stuff out.
Recent AMRN News
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:31:21 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM